Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B. (Q44079403)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B. |
scientific article |
Statements
1 reference
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B. (English)
1 reference
1 reference
Maria Buti
1 reference
Edward Gane
1 reference
Seng G Lim
1 reference
Adrian DiBisceglie
1 reference
Anuchit Chutaputti
1 reference
Jens Rasenack
1 reference
Jinlin Hou
1 reference
Christopher O'Brien
1 reference
Tuan T Nguyen
1 reference
Jidong Jia
1 reference
Bruce Belanger
1 reference
Weibin Bao
1 reference
Nikolai V Naoumov
1 reference
12 February 2009
1 reference
1 reference
Identifiers
1 reference